Publication | Open Access
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
18
Citations
0
References
2020
Year
Ruxolitinib CreamAbstract AlgebraAllergyAtopic DermatitisAllergy MedicineSkin AllergyClinical DermatologyDermatologySclerodermaMedicineAbstract Object TheoryPhase 3
Abstract not available.